肺动脉内膜剥脱术与球囊肺动脉成形术治疗慢性血栓栓塞性肺动脉高压后右心室重构及长期生存比较
这项前瞻性观察队列研究比较了肺动脉内膜剥脱术(PEA,n=54)与球囊肺动脉成形术(BPA,n=44)治疗慢性血栓栓塞性肺动脉高压(CTEPH)后的右心室重构和远期生存。两组均出现显著右心室逆重构,PEA组三尖瓣反流压下降幅度更大(26±18 vs 13±21 mm Hg,P=0.02),TAPSE变化方向相反;5年生存率PEA组96%、BPA组79%,差异无统计学意义(P=0.25)。右心室面积变化分数(RV FAC)改善是生存的独立预测因素。
要点
- PEA与BPA均可显著改善CTEPH患者的右心室重构指标。
- PEA组三尖瓣反流压下降幅度大于BPA组,TAPSE变化方向相反。
- RV FAC改善是生存的独立预测因素,提示右心室功能恢复的重要性。
核心结论
- PEA和BPA均能导致显著的右心室逆重构,生存率差异无明确证据。
- 右心室功能改善,尤其是RV FAC改善,与更好的结局相关。
研究设计与样本
- 前瞻性观察性队列研究,纳入2011至2022年间接受PEA(n=54)或BPA(n=44)的CTEPH患者。
- 在基线和随访时进行超声心动图检查。
主要发现
- 两组左心室收缩末期偏心指数、右心室基底径和RV FAC均显著改善。
- PEA组三尖瓣反流压下降26±18 mm Hg,BPA组下降13±21 mm Hg(组间差异P=0.02)。
- PEA组TAPSE下降4±5 mm,BPA组增加1±4 mm(P<0.001)。
- 两组TAPSE/收缩期肺动脉压比值改善程度相似。
- PEA组5年生存率96%(95%CI 86%至99%),BPA组79%(95%CI 61%至89%),P=0.25。
临床怎么用
- 在CTEPH治疗中应重视右心室功能恢复的评估,尤其是RV FAC的变化。
- PEA与BPA均可作为改善右心室重构的治疗选择,需根据患者可手术性个体化决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pulmonary endarterectomy (PEA) is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), while balloon pulmonary angioplasty (BPA) is an alternative for inoperable patients. We aimed to compare right ventricular (RV) remodelling and late survival after PEA and BPA. METHODS: In this prospective observational cohort study, we performed echocardiography at baseline and follow-up in patients with CTEPH treated with PEA (n=54) or BPA (n=44) between 2011 and 2022. RESULTS: Follow-up echocardiography was performed at 5 months (IQR 4-7) after PEA and 3 months (IQR 2-4) after the last BPA. Both groups showed significant improvements in left ventricular end-systolic eccentricity index, RV basal diameter and RV fractional area change (RV FAC). Tricuspid regurgitation pressure decreased by 26±18 mm Hg after PEA and 13±21 mm Hg after BPA (p=0.02 for between-group difference). Tricuspid annular systolic excursion (TAPSE) decreased by 4±5 mm after PEA but increased by 1±4 mm after BPA (p<0.001). The TAPSE/systolic pulmonary artery pressure ratio improved similarly in both groups. Five-year survival was 96% (95% CI 86% to 99%) for PEA and 79% (95% CI 61% to 89%) for BPA (p=0.25). Change in RV FAC was an independent predictor of survival (HR 0.9, 95% CI 0.82 to 0.99, p=0.03). CONCLUSIONS: Both PEA and BPA led to significant RV reverse remodelling, with no clear evidence of a difference in survival rates. Improvement in RV function, particularly RV FAC, was associated with better outcomes, highlighting the importance of RV recovery in CTEPH treatment.
引用
- Ravnestad H, Murbræch K, Gjønnæss E, et al. Right ventricular remodelling and long-term survival after pulmonary endarterectomy versus balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension. Heart. 2025. PMID: 39467613. doi:10.1136/heartjnl-2024-324243
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。